from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3665c/dppB

LFCtreatmentdescriptionclass of inhibitor

1.285

Amikacinug/mL Amikacintranslation

-0.165

Cap5-10ug/mL Capreomycintranslation

-0.524

Rox10-50 ug/mL Roxithromycintranslation

0.062

SM2-5 ug/mL Streptomycintranslation

-0.063

Tet5-10 ug/mL Tetracyclinetranslation

1.114

Rif0.2-5ug/mL Rifampicintranscription

0.291

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.689

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.731

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.478

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.450

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.138

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.284

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.448

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-2.551

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.219

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.496

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.158

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.390

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.866

KCN5-20 ug/mL Potassium cyaniderespiration

-1.064

NaN30.2-2 mM Sodium aziderespiration

-0.621

Nigericin50 uM Nigericinrespiration

-0.131

TRC10-150 ug/mL Triclosanrespiration

0.339

TRZ10-25 ug/mL Thioridazinerespiration

0.000

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.266

menadione6-10 ug/mL Menadionerespiration

-0.185

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.269

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.484

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.689

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.928

NRP_1Non-replicating persistence stage 1dosRassociated

0.867

Amp0.2mg/mL AmpicillincellWall

-0.196

Cephalexin20-100 ug/mL CephalexincellWall

1.622

Cerulenin0.32-5 ug/mL CerulenincellWall

0.467

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

1.010

EMB10-20 ug/mL EthambutolcellWall

0.395

Eta12-40 ug/mL EthionamidecellWall

-0.079

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.441

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.136

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.579

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.075

BZA0.12 mg/mL BenzamidearomaticAmides

0.332

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.224

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.000

H2O24 mM hydrogen peroxideDNAdamaging

-0.047

Levo10 ug/mL LevofloxacinDNAdamaging

-0.269

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.044

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.472

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.187

UVUV-irradiationDNAdamaging

-0.122

ARP41-4 ug/mL Antitubercular compound ARP4?

0.492

Antimycin12.5-50 ug/mL Antimycin A?

-0.455

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.040

PA_110-50 ug/mL Antitubercular compound PA-1?

0.369

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.774

PA8240.2-2 ug/mL PA-824?

-0.326

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.060

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.775

Verapamil50 uM Verapamil?

-0.365

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.214

methoxatin10-20 ug/mL Methoxatin?